Taiwan Liposome Layoffs - TheLayoff.com

Taiwan Liposome company profile

Messages relating to layoffs at Taiwan Liposome are presented below the company info.

Company information:

Industry/Area of Activity:

Biotech

Company Stock Ticker:

TLC

Stock traded at:

XNAS

About Taiwan Liposome:

Taiwan Liposome Company (TLC) is a biopharmaceutical company. The company covers the end-to-end bio-tech production and sales process and specializes in developing and manufacturing lipid-based formulations of drugs for targeted delivery. The company's proprietary LipAD technology enables the encapsulation of drugs in lipid nanoparticles, which can improve drug efficacy and safety. TLC has partnerships with pharmaceutical companies such as Hikma Pharmaceuticals and CytoPharm to develop and commercialize its products globally. The company is listed on the Taiwan Stock Exchange under the ticker symbol "4152". Competitors in the liposomal drug delivery market include companies such as Sun Pharmaceutical Industries, Gilead Sciences, and Pacira Biosciences.

Contact information:

http://www.tlcbio.com

More information:

Year Founded: 1997
HQ Location:: Taipei, T'ai-pei, Taiwan
Keywords: Life-Sciences, Biotech, Molecular-Science, Healthcare, Medical

Related companies:

Comment! It's anonymous!

There are no posts about Taiwan Liposome yet. Be the first to comment:

Topics regarding layoffs at Taiwan Liposome

Start a new thread - post a news comment, question or message: